Literature DB >> 24440998

Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.

Chahinda Ghossein-Doha1, Marc Spaanderman2, Sander M J van Kuijk3, Abraham A Kroon4, Tammo Delhaas5, Louis Peeters6.   

Abstract

INTRODUCTION: Women with former preeclampsia (exPE) develop chronic hypertension 4 times more often than healthy parous controls. Women, destined to develop remote chronic hypertension, had increased left ventricular mass index (LVMI) and diastolic blood pressure (BP) prior to the onset of hypertension as compared to those remaining normotensive. However, longitudinal data on the progress of this increased LVMI in women destined to develop hypertension are lacking.
METHODS: We included 20 women with exPE and 8 parous controls. At both 1- and 14-year postpartum (pp), we performed cardiac ultrasound and determined circulating levels of the metabolic syndrome variables. Of 14-year pp, 7 (35%) former patients had developed chronic hypertension. We compared these 7 former patients with both the 13 former patients who remained normotensive and the 8 parous controls using the Mann-Whitney U test and Kruskal-Wallis analysis.
RESULTS: Women with hypertensive exPE differed from their normotensive counterparts by a higher incidence of early-onset preeclampsia (PE) in their index pregnancy and a higher rate of recurrence in next pregnancies. At 1-year pp, they also had high/normal BP and higher fasting insulin levels. At 14 years pp, the relative left ventricular wall thickness was higher, and the E/A ratio was lower, in the hypertensive group relative to those remaining normotensive.
CONCLUSION: Women with exPE are at increased risk of developing chronic hypertension, when (1) the PE in the index pregnancy had an early-onset and/or recurred in next pregnancies and (2) the 1-year pp. Blood pressure was high normal. We also noticed that at 14 years pp, the hypertensive group showed signs of concentric left ventricular remodeling along with a decreased E/A ratio.
© The Author(s) 2014.

Entities:  

Keywords:  concentric hypertrophy; hypertension; left ventricular mass; preeclampsia

Year:  2014        PMID: 24440998      PMCID: PMC4107566          DOI: 10.1177/1933719113518989

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  24 in total

1.  Missing data techniques for structural equation modeling.

Authors:  Paul D Allison
Journal:  J Abnorm Psychol       Date:  2003-11

2.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

3.  Changes in hemodynamic parameters and volume homeostasis with the menstrual cycle among women with a history of preeclampsia.

Authors:  M E Spaanderman; E Van Beek; T H Ekhart; J Van Eyck; E C Cheriex; P W De Leeuw; L L Peeters
Journal:  Am J Obstet Gynecol       Date:  2000-05       Impact factor: 8.661

4.  Preeclampsia is associated with persistent postpartum cardiovascular impairment.

Authors:  Karen Melchiorre; George Ross Sutherland; Marco Liberati; Basky Thilaganathan
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

5.  Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia?

Authors:  A E Barden; L J Beilin; J Ritchie; B N Walters; C Michael
Journal:  J Hypertens       Date:  1999-09       Impact factor: 4.844

6.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

Review 7.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David J Williams
Journal:  BMJ       Date:  2007-11-01

8.  Hypertension after preeclampsia is preceded by changes in cardiac structure and function.

Authors:  Chahinda Ghossein-Doha; Louis Peeters; Sanne van Heijster; Sander van Kuijk; Julia Spaan; Tammo Delhaas; Marc Spaanderman
Journal:  Hypertension       Date:  2013-06-03       Impact factor: 10.190

9.  New Dutch reference curves for birthweight by gestational age.

Authors:  Gerard H A Visser; Paul H C Eilers; Patty M Elferink-Stinkens; Hans M W M Merkus; Jan M Wit
Journal:  Early Hum Dev       Date:  2009-11-13       Impact factor: 2.079

10.  Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study.

Authors:  Sonia Hernández-Díaz; Sengwee Toh; Sven Cnattingius
Journal:  BMJ       Date:  2009-06-18
View more
  10 in total

Review 1.  Pre-eclampsia and long-term cardiac dysfunction: A review of asymptomatic cardiac changes existing well beyond the post-partum period.

Authors:  Archana S Thayaparan; Joanne M Said; Sandra A Lowe; Anthony McLean; Yang Yang
Journal:  Australas J Ultrasound Med       Date:  2019-07-02

2.  Cerebrovascular Reactivity and Vascular Activation in Postmenopausal Women With Histories of Preeclampsia.

Authors:  Jill N Barnes; Ronée E Harvey; Kathleen B Miller; Muthuvel Jayachandran; Katherine R Malterer; Brian D Lahr; Kent R Bailey; Michael J Joyner; Virginia M Miller
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

3.  Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis.

Authors:  L Brouwers; A J van der Meiden-van Roest; C Savelkoul; T E Vogelvang; A T Lely; A Franx; B B van Rijn
Journal:  BJOG       Date:  2018-08-10       Impact factor: 6.531

Review 4.  Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications.

Authors:  Wilfried Gyselaers
Journal:  J Clin Med       Date:  2019-03-11       Impact factor: 4.241

5.  Multicenter Cohort Study, With a Nested Randomized Comparison, to Examine the Cardiovascular Impact of Preterm Preeclampsia.

Authors:  Fergus P McCarthy; Jamie M O'Driscoll; Paul T Seed; Anna Placzek; Carolyn Gill; Jenie Sparkes; Lucilla Poston; Mike Marber; Andrew H Shennan; Basky Thilaganathan; Paul Leeson; Lucy C Chappell
Journal:  Hypertension       Date:  2021-08-30       Impact factor: 10.190

6.  Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study.

Authors:  Tobias F S Pustjens; Nousjka P A Vranken; Gwyneth Jansen; Patty J C Winkler; Mera Stein; Loes Hoebers; Bas Kietselaer; Marc E A Spaanderman; Saman Rasoul; Chahinda Ghossein-Doha; Arnoud W J van 't Hof
Journal:  Front Cardiovasc Med       Date:  2022-07-15

7.  Risk of future cardiovascular diseases in different years postpartum after hypertensive disorders of pregnancy: A systematic review and meta-analysis.

Authors:  Jarawee Sukmanee; Tippawan Liabsuetrakul
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

8.  The Association Between Hypertensive Disorders in Pregnancy and the Risk of Developing Chronic Hypertension.

Authors:  Jiahao Xu; Ting Li; Yixiao Wang; Lu Xue; Zhijing Miao; Wei Long; Kaipeng Xie; Chen Hu; Hongjuan Ding
Journal:  Front Cardiovasc Med       Date:  2022-07-07

9.  Oxidative stress and endothelial function in normal pregnancy versus pre-eclampsia, a combined longitudinal and case control study.

Authors:  Dominique Mannaerts; Ellen Faes; Jan Gielis; Emeline Van Craenenbroeck; Paul Cos; Marc Spaanderman; Wilfried Gyselaers; Jerome Cornette; Yves Jacquemyn
Journal:  BMC Pregnancy Childbirth       Date:  2018-02-27       Impact factor: 3.007

Review 10.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.